Hofstee P, Bartho LA, McKeating DR, et al
AOD-9604 may theoretically interact with beta-blockers by antagonising beta-3 receptor signalling, though this hasnt been clinically documented
If your liver is impaired, your body may be unable to efficiently convert T4 to the active T3 hormone
This medication works by binding to two receptors (GLP-1 and GIP) simultaneously to suppress appetite, support weight loss, and promote metabolic health
Changes in the medication's appearance may indicate degradation, contamination, or improper storage that renders the medication unsafe or ineffective
After this "reset," restarting the peptide often produces a second wave of effectiveness often better than the first